Skip to main content
Joel Palefsky, MD, Infectious Disease, San Francisco, CA

Joel M. Palefsky MD


Professor, Medicine, UCSF School of Medicine

Join to view full profile
  • 1600 Divisadero StSan Francisco, CA 94143

  • Phone+1 415-353-7100

  • Fax+1 415-353-7150

Dr. Palefsky is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - 2028
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Initial Development and Content Validation of a Health-Related Symptom Index for Persons Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions  
    Timothy J Wilkin, Joel M Palefsky, Value in Health

Lectures

  • Cancer Prevention Through Human Papillomavirus Vaccination 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
  • High Resolution Anoscopy (HRA) 
    American Society for Colposcopy and Cervical Pathology, Providence, Rhode Island - 4/27/2012

Other

Authored Content

  • Initial Development and Content Validation of a Health-Related Symptom Index for Persons Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial LesionsAugust 2018

Press Mentions

  • Winship Contributes to Anal Cancer/HSIL Outcomes Research (ANCHOR) Study
    Winship Contributes to Anal Cancer/HSIL Outcomes Research (ANCHOR) StudyJuly 13th, 2022
  • Risk of Anal Cancer Significantly Lower with Treatment for Anal High-Grade Squamous Intraepithelial Lesions
    Risk of Anal Cancer Significantly Lower with Treatment for Anal High-Grade Squamous Intraepithelial LesionsJune 22nd, 2022
  • Screening and Early Treatment Reduces Anal Cancer in People with HIV
    Screening and Early Treatment Reduces Anal Cancer in People with HIVJune 17th, 2022

Grant Support

  • California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ PopulationsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2026
  • Mechanisms of disparities in the natural history of oral and oropharyngeal HPV infection among persons living with HIV: the CAMPO oral cohort studyCOMPREHENSIVE CANCER CENTER/ UNIV/PR2022–2025
  • Incidence Of HIV Among Indian Men WHO Have Sex With MenNational Cancer Institute2011
  • Hpv-Related Neoplasia Among Hiv-Seropositive Indian Men WHO Have Sex With MenNational Cancer Institute2011
  • E6 Oncoprotein Based Rapid Test For Anal NeoplasiaNational Cancer Institute2010–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: